Journal of inherited metabolic disease · 2013
Cross-sectional observational study of 208 patients with non-classical urea cycle disorders.
СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rüegger Corinne M, Lindner Martin, Ballhausen Diana, Baumgartner Matthias R, Beblo Skadi, Das Anibh, Gautschi Matthias, Glahn Esther M, Grünert Sarah C, Hennermann Julia, Hochuli Michel, Huemer Martina, Karall Daniela, Kölker Stefan, Lachmann Robin H, Lotz-Havla Amelie, Möslinger Dorothea, Nuoffer Jean-Marc, Plecko Barbara, Rutsch Frank, Santer René, Spiekerkoetter Ute, Staufner Christian, Stricker Tamar, Wijburg Frits A, Williams Monique, Burgard Peter, Häberle Johannes
Аннотация
Urea cycle disorders (UCDs) are inherited disorders of ammonia detoxification often regarded as mainly of relevance to pediatricians. Based on an increasing number of case studies it has become obvious that a significant number of UCD patients are affected by their disease in a non-classical way: presenting outside the newborn period, following a mild course, presenting with unusual clinical features, or asymptomatic patients with only biochemical signs of a UCD. These patients are surviving into adolescence and adulthood, rendering this group of diseases clinically relevant to adult physicians as well as pediatricians. In preparation for an international workshop we collected data on all patients with non-classical UCDs treated by the participants in 20 European metabolic centres. Information was collected on a cohort of 208 patients 50% of which were ≥ 16 years old. The largest subgroup (121 patients) had X-linked ornithine transcarbamylase deficiency (OTCD) of whom 83 were female and 29% of these were asymptomatic. In index patients, there was a mean delay from first symptoms to diagnosis of 1.6 years. Cognitive impairment was present in 36% of all patients including female OTCD patients (in 31%) and those 41 patients identified presymptomatically following positive newborn screening (in 12%). In conclusion, UCD patients with non-classical clinical presentations require the interest and care of adult physicians and have a high risk of neurological complications. To improve the outcome of UCDs, a greater awareness by health professionals of the importance of hyperammonemia and UCDs, and ultimately avoidance of the still long delay to correctly diagnose the patients, is crucial.
Предметные рубрики MeSH
AdolescentAdultAge of OnsetAgedArginineChildChild, PreschoolCitrullineCognition DisordersCohort StudiesCross-Sectional StudiesDiet TherapyFemaleHumansInfantInfant, NewbornMaleMiddle AgedNeonatal ScreeningOrnithine Carbamoyltransferase Deficiency DiseaseTime FactorsTreatment OutcomeUrea Cycle Disorders, InbornYoung Adult